Prosecution Insights
Prosecution Insights
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Double-patenting + other | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RYAN, DOUGLAS CHARLES | 1 | 40.3% | +50.7% |
| BRETZ, COREY LANE | 1 | 0.0% | +0.0% |
| GODDARD, LAURA B | 1 | 51.0% | +14.0% |
| PRONZATI, GINA | 1 | 65.7% | +45.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17913728 | FORSKOLIN-INDUCIBLE PROMOTERS AND HYPOXIA-INDUCIBLE PROMOTERS | BRETZ, COREY LANE | 29d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17793196 | RECOMBINANT AAV PRODUCTION | GODDARD, LAURA B | 35d |
| 17918277 | FORSKOLIN-INDUCIBLE PROMOTERS AND HYPOXIA-INDUCIBLE PROMOTERS | RYAN, DOUGLAS CHARLES | — |
| 17788679 | REGULATORY NUCLEIC ACID SEQUENCES | PRONZATI, GINA | — |
| Art Unit | Apps |
|---|---|
| 1635 | 2 |
| 1642 | 1 |
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17918277 | FORSKOLIN-INDUCIBLE PROMOTERS AND HYPOXIA-INDUCIBLE PROMOTERS | RYAN, DOUGLAS CHARLES | 1635 | §103§112DP | Final Rejection | — | Pending | Oct 11, 2022 |
| 17913728 | FORSKOLIN-INDUCIBLE PROMOTERS AND HYPOXIA-INDUCIBLE PROMOTERS | BRETZ, COREY LANE | 1635 | §101§103§112Other | Final Rejection | 29d overdue | Pending | Sep 22, 2022 |
| 17793196 | RECOMBINANT AAV PRODUCTION | GODDARD, LAURA B | 1642 | §103 | Non-Final OA | 35d | Pending | Jul 15, 2022 |
| 17788679 | REGULATORY NUCLEIC ACID SEQUENCES | PRONZATI, GINA | 1633 | §102§103DP | Non-Final OA | — | Pending | Jun 23, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial